Showing 1591-1600 of 10578 results for "".
The Heritage of Platelet-Derived Growth Factor
https://practicaldermatology.com/topics/regenerative-medicine/the-heritage-of-pdgf/48868/From its discovery nearly half a century ago to its current place in patient care and scientific conversation in aesthetic medicine, poorly healing skin wounds, orthopedics, and dental surgical reconstruction, platelet-derived growth factor (PDGF) stands as both a milestone of molecular biology andA Definitive Guide to Recognizing and Treating “Maskne”
https://practicaldermatology.com/columns/clinical-focus-1/a-definitive-guide-to-recognizing-and-treating-maskne/23520/Practical Dermatology® magazine’s resident acne columnist offers step-by-step guidance.Comorbidities in Alopecia Areata
https://practicaldermatology.com/issues/july-2025/comorbidities-in-alopecia-areata/36507/Alopecia areata (AA) is a chronic, relapsing immune-mediated disorder that causes nonscarring hair loss that can significantly impact a patient’s quality of life.Non-genital Warts: A Review of Current Treatments
https://practicaldermatology.com/topics/general-topics/non-genital-warts-a-review-of-current-treatments/21884/When determining which treatment modality to choose for non-genital warts, there are several factors to consider, including the convenience of the treatment, patient discomfort, location of warts, and potential side effects.Navigating Industry: Tips for Successful Relationships and Partnerships
https://practicaldermatology.com/issues/january-february-2025/navigating-industry-tips-for-successful-relationships-and-partnerships/32976/Dermatology is no longer confined to the physician-patient interaction in a busy clinic, private practice office, or academic center.How do barrier dysfunction proteins interact with immune dysregulation to sustain AD?
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/how-do-barrier-dysfunction-proteins-interact-with-immune-dysregulation-to-sustain-ad/56736/Raj Chovatiya, MD, PhD, MSCI, FAAD, discusses whether barrier dysfunction drives inflammation and immune dysregulation, or vice versa, or both, in atopic dermatitis.Advances in Topicals for Skin Conditions
https://practicaldermatology.com/topics/psoriasis/advances-in-topicals-for-skin-conditions/20197/There are more topicals available today than ever before for acne, rosacea, and psoriasis, and even more are coming down the pike. Larry Green, MD, reviews the current topical landscape in dermatology and previews what’s in the pipeline.See how ILUMYA™ works
https://practicaldermatology.com/topics/psoriasis/see-how-ilumya-works/19857/Learn about the immunopathogenesis of plaque psoriasis, and how the IL-23 inhibitor ILUMYA™ controls the release of key cytokines to continuously maintain immune homeostasis.Spectra VRM II Tattoo Removal
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/tattoo-removal/19524/Description of pulse duration and wavelength for chromophores and demonstrates tattoo removal in African-American patient.DermWire TV Extra: Dr. Bunick on BPO Study
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-extra-dr-bunick-bpo-study/29165/Practical Dermatology Editorial Board member Christopher Bunick, MD, FAAD, discusses the new Journal of Investigative Dermatology article he co-authored, "Evaluation of Benzene Presence and Formulation in Benzoyl Peroxide Drug Products."